Skip to main content

/ health information/ Group items tagged crohn's-disease-drugs

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

AstraZeneca to stop developing Crohn's disease drug - 0 views

www.pharmacy.biz/developing-crohns-disease-drug

crohn's-disease-drugs pharmacy-business crohn's-disease-injection-treatment Treatment-for-Crohn's-disease astrazeneca-news astrazeneca-news-for-drug-brazikumab

shared by pharmacybiz on 02 Jun 23 - No Cached

pharmacybiz on 02 Jun 23

British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis. The company said the discontinuation was due to a delay in the drug's development timeline, affected by global events and "the context of a competitive landscape". AstraZeneca regained the rights to brazikumab from Allergan in 2020 following U.S. drugmaker AbbVie's $63 billion tie-up with Allergan. AbbVie will stop funding the drug's development, AstraZeneca said. AbbVie's Skyrizi also treats Crohn's disease.

<div class="cArrow"> </div><div class="cContentInner">British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis. The company said the discontinuation was due to a delay in the drug's development timeline, affected by global events and "the context of a competitive landscape". AstraZeneca regained the rights to brazikumab from Allergan in 2020 following U.S. drugmaker AbbVie's $63 billion tie-up with Allergan. AbbVie will stop funding the drug's development, AstraZeneca said. AbbVie's Skyrizi also treats Crohn's disease. </div>

...

Cancel

1 - 1 of 1

Showing 20▼ items per page

Related searches